<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03582852</url>
  </required_header>
  <id_info>
    <org_study_id>2017-43</org_study_id>
    <secondary_id>2017-A02650-53</secondary_id>
    <nct_id>NCT03582852</nct_id>
  </id_info>
  <brief_title>Laparoscopic Sacrocolpexy Versus Lateral Suspension</brief_title>
  <acronym>SUSPENSION</acronym>
  <official_title>Laparoscopic Sacrocolpexy Versus Lateral Suspension With a Mesh for the Treatment of Pelvic Organ Prolapse : a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical treatment of genital prolapse can be performed by laparoscopic surgery or by vaginal&#xD;
      surgery, with or without using meshes. Laparoscopic sacrocolpopexy, which consist in fixing a&#xD;
      mesh between vaginal anterior wall and the promontory is the gold standard procedure to treat&#xD;
      anterior prolapse or of the vaginal vault. Most of studies shows a success rate of 80% of&#xD;
      this procedure.&#xD;
&#xD;
      However, access to the promontory could be difficult in patients because of adherences or&#xD;
      anatomical reasons. This step of the procedure also exposes to risk of ureteral or vascular&#xD;
      injuries. Recent issues have also found spondylodiscitis cases.&#xD;
&#xD;
      The technique of laparoscopic lateral suspension with mesh was developed by Dubuisson in 1998&#xD;
      allows not to have to approach the promontory and avoids both the risk of vascular injury and&#xD;
      ureteral damage of laparoscopic sacrocolpopexy. Instead of attach the mesh to the promontory,&#xD;
      the procedure consists in spreading out bilaterally, a subperitoneal T-shaped mesh in the&#xD;
      anterior abdominal wall. The aim of this study is to compare the clinical and functional&#xD;
      efficiency of the lateral suspension versus laparoscopic sacrocolpopexy.&#xD;
&#xD;
      It is a prospective, randomized, monocentric study compared two groups The study hypothesis&#xD;
      is that the lateral suspension would provide correction than the laparoscopic sacrocolpopexy.&#xD;
&#xD;
      The primary outcome is the comparison of anatomic correction rates at 1 year Success is&#xD;
      defined as 1 year Ba et C points &lt; -1 centimeter in POP-Q international score.&#xD;
&#xD;
      Secondary endpoints are improve of quality of life evaluated with the validated P-QOL&#xD;
      questionnaire, and complications rates, including post-operative posterior prolapse.&#xD;
&#xD;
      Number of subjects required is 72 patients, 36 in each group having a laparoscopic&#xD;
      sacrocolpopexy or lateral suspension.&#xD;
&#xD;
      Outcomes will be evaluated at 1 month and 1 year post-operative consultation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">April 12, 2018</start_date>
  <completion_date type="Anticipated">April 11, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 11, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate cervico-urethral hypermobility</measure>
    <time_frame>one year</time_frame>
    <description>Success is defined by two points inferior at 1 centimeter in Pelvic organs prolapse quantification (POP-Q) international score. defining a symptomatic or asymptomatic state</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>promontory</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic sacrocolpopexy, which consist in fixing a mesh between vaginal anterior wall</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic lateral suspension</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The procedure consists in spreading out bilaterally, a subperitoneal T-shaped mesh in the anterior abdominal wall</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical treatment of genital prolapse</intervention_name>
    <description>Laparoscopy performed according to the usual technique of the participating center with pneumoperitoneum between 12 and 15 mmHg. Placement of the 5 mm trocar operator left and right iliac fossa and 5 mm pubic addition.</description>
    <arm_group_label>laparoscopic lateral suspension</arm_group_label>
    <arm_group_label>promontory</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients at least 18 years old.&#xD;
&#xD;
          -  Patients who agreed to participate in the study and signed informed consent.&#xD;
&#xD;
          -  Patient affiliated to a social protection system.&#xD;
&#xD;
          -  Surgical indication by laparoscopy of prolapse cure symptomatic of the anterior stage&#xD;
             and / or isolated medium.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minor patient.&#xD;
&#xD;
          -  Patient refusing to sign the consent or unable to receive the necessary information to&#xD;
             give informed consent.&#xD;
&#xD;
          -  Patient not affiliated to a social protection system.&#xD;
&#xD;
          -  Presence of one or more contraindication (s) to laparoscopy&#xD;
&#xD;
          -  Presence of posterior prolapse requiring surgical treatment&#xD;
&#xD;
          -  Need for an associated surgical procedure.&#xD;
&#xD;
          -  Major people under legal protection&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Olivier ARNAUD, Director</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aubert AGOSTINI, PU-PH</last_name>
    <phone>491383785</phone>
    <phone_ext>+33</phone_ext>
    <email>aubert.agostini@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire TOURETTE, PH</last_name>
    <phone>491383785</phone>
    <phone_ext>+33</phone_ext>
    <email>claire.tourette@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aubert AGOSTINI, PU-PH</last_name>
      <phone>491383785</phone>
      <phone_ext>+33</phone_ext>
      <email>aubert.agostini@ap-hm.fr</email>
    </contact>
    <contact_backup>
      <last_name>PH</last_name>
      <phone>491383785</phone>
      <phone_ext>+33</phone_ext>
      <email>claire.tourette@ap-hm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Aubert AGOSTINI, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire TOURETTE, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 22, 2018</study_first_submitted>
  <study_first_submitted_qc>June 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2018</study_first_posted>
  <last_update_submitted>June 27, 2018</last_update_submitted>
  <last_update_submitted_qc>June 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

